Diabetes mellitus as a risk factor for intervertebral disc degeneration: a critical review
To examine to what extent diabetes mellitus (DM) is implicated as a distinct mechanism in intervertebral disc degeneration (IVDD).
The published clinical and laboratory data relevant to this matter are critically reviewed. A total of 12 clinical studies evaluate the association between DM and degenerative changes such as IVDD, spinal stenosis (SS) and IVD herniation. A total of 34 laboratory research papers evaluate the association between DM and IVDD.
There are 7 studies that correlate DM with IVDD, 4 of them showing that DM is a significant risk factor for degeneration, and 3 of them failing to establish any association. Three studies demonstrate significant association between DM and SS. However, 2 of these studies also include patients with IVD herniation that failed to demonstrate any correlation with DM. Two other studies indicate a significant association between DM and lumbar disc herniation. Multiple different mechanisms, acting independently or interactively, cause tissue damage leading to IVDD including: microangiopathy of the subchondral vertebral endplate, cellular senescence, cell death (through apoptosis or autophagy), hyperglycaemia, advance glycation end products, adipokines, and cytokines (through oxidative, osmotic, and inflammatory mechanisms).
The clinical evidence is not consistent, but weakly supports the relationship between DM and IVDD. However, the laboratory studies consistently suggest that DM interferes with multipronged aberrant molecular and biochemical pathways that provoke IVDD. Taken as a whole, the strong laboratory evidence and the weak clinical studies implicate DM as a distinct contributing factor for IVDD.
KeywordsIntervertebral disc degeneration Diabetes mellitus Hyperglycaemia Clinical studies Molecular and biochemical mechanisms
Compliance with ethical standards
Conflict of interest
The authors state no conflict of interest.
- 1.Silberberg R (1986) The skeleton in diabetes mellitus: a review of the literature. Diabetes Res 3(7):329–338Google Scholar
- 13.Anekstein Y, Smorgick Y, Lotan R et al (2010) Diabetes mellitus as a risk factor for the development of lumbar spinal stenosis. Isr Med Assoc J 12(1):16–20Google Scholar
- 17.Tofthagen C (2012) Threats to validity in retrospective studies. J Adv Pract Oncol. 3(3):181–183Google Scholar
- 18.Shemesh S, Sidon E, Kaisler E et al (2018) Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study. Eur Spine J 27(7):1614–1622. https://doi.org/10.1007/s00586-017-5315-0 CrossRefGoogle Scholar
- 22.Antoniou J, Steffen T, Nelson F et al (1996) The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Investig 98(4):996–1003. https://doi.org/10.1172/JCI118884 CrossRefGoogle Scholar
- 47.Silberberg R (1988) The vertebral column of diabetic sand rats (Psammomys obesus). Exp Cell Biol 56(4):217–220Google Scholar
- 48.Aufdermaur M, Fehr K, Lesker P, Silberberg R (1980) Quantitative histochemical changes in intervertebral discs in diabetes. Exp Cell Biol 48(2):89–94Google Scholar
- 50.Miao D, Zhang L (2015) Leptin modulates the expression of catabolic genes in rat nucleus pulposus cells through the mitogen-activated protein kinase and Janus kinase 2/signal transducer and activator of transcription 3 pathways. Mol Med Rep 12(2):1761–1768. https://doi.org/10.3892/mmr.2015.3646 CrossRefGoogle Scholar
- 52.Kaplan M, Arici L, Ozturk S, Simsek BC, Hergunsel OB, Erol FS (2018) A comparison of the type IX collagen levels of the intervertebral disc materials in diabetic and non-diabetic patients who treated with lumbar microdiscectomy. Eur Spine J 27(1):214–221. https://doi.org/10.1007/s00586-017-5361-7 CrossRefGoogle Scholar
- 55.Qi L, Wang R, Shi Q, Yuan M, Jin M, Li D (2018) Umbilical cord mesenchymal stem cell conditioned medium restored the expression of collagen II and aggrecan in nucleus pulposus mesenchymal stem cells exposed to high glucose. J Bone Miner Metab. https://doi.org/10.1007/s00774-018-0953-9 Google Scholar